ABSTRACT

The third edition of this well-received text provides a state-of-the-art treatise on modern clinical practice relating to hyperlipidaemia and lipoprotein disorders, conditions responsible for a huge amount of morbidity and mortality in Western countries and, increasingly, the developing world. The clinical evidence underlying the treatment of

chapter |1 pages

Introduction

chapter |1 pages

REFERENCES

chapter 1|12 pages

Lipids and their metabolism

chapter |4 pages

INTESTINAL FAT ABSORPTION

chapter 2|22 pages

Lipoproteins and their metabolism

LIPOPROTEIN STRUCTURE

chapter |2 pages

APOLIPOPROTEINS

chapter |7 pages

Apolipoprotein B

chapter |1 pages

LECITHIN:CHOLESTEROL ACYLTRANSFERASE

chapter 3|16 pages

Serum lipid and lipoprotein concentrations in health and in disease

WHAT ARE NORMAL SERUM LIPID LEVELS?

chapter |7 pages

Apolipoproteins

chapter 4|2 pages

Familial hypercholesterolaemia

chapter |12 pages

CLINICAL FEATURES

chapter |9 pages

Dietary treatment

chapter |14 pages

TRIALS OF FIBRIC ACID DERIVATIVES

chapter 6|6 pages

Hypertriglyceridaemia

chapter 7|23 pages

Type III hyperlipoproteinaemia

CLINICAL FEATURES General

chapter 8|6 pages

Diet

chapter |22 pages

OBESITY

chapter |16 pages

Patients with hypertriglyceridaemia

chapter 9|8 pages

Lipid-modifying therapy

STATINS (3-HYDROXY, 3-METHYL-GLUTARYL-CoA REDUCTASE INHIBITORS)

chapter |3 pages

Statin resistance

chapter |6 pages

FIBRIC ACID DERIVATIVES

chapter |17 pages

NIACIN (NICOTINIC ACID)

chapter |16 pages

TYPE 1 AND TYPE 2 DIABETES

chapter 11|21 pages

Secondary hyperlipidaemia

chapter |8 pages

Anorexia nervosa

chapter |21 pages

Retinoic acid derivatives

chapter |1 pages

This page intentionally left blank